116 related articles for article (PubMed ID: 9521690)
1. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.
Starling GC; Kiener PA; Aruffo A; Bajorath J
Biochemistry; 1998 Mar; 37(11):3723-6. PubMed ID: 9521690
[TBL] [Abstract][Full Text] [Related]
2. Identification of the ligand binding site in Fas (CD95) and analysis of Fas-ligand interactions.
Bajorath J
Proteins; 1999 Jun; 35(4):475-82. PubMed ID: 10382675
[TBL] [Abstract][Full Text] [Related]
3. A family of ligands for the TNF receptor superfamily.
Cosman D
Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
[TBL] [Abstract][Full Text] [Related]
4. Construction and analysis of a detailed three-dimensional model of the ligand binding domain of the human B cell receptor CD40.
Bajorath J; Aruffo A
Proteins; 1997 Jan; 27(1):59-70. PubMed ID: 9037712
[TBL] [Abstract][Full Text] [Related]
5. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Ju ST
J Immunol; 1998 Oct; 161(7):3469-73. PubMed ID: 9759866
[TBL] [Abstract][Full Text] [Related]
6. The three-dimensional solution structure and dynamic properties of the human FADD death domain.
Berglund H; Olerenshaw D; Sankar A; Federwisch M; McDonald NQ; Driscoll PC
J Mol Biol; 2000 Sep; 302(1):171-88. PubMed ID: 10964568
[TBL] [Abstract][Full Text] [Related]
7. The role of polar interactions in the molecular recognition of CD40L with its receptor CD40.
Singh J; Garber E; Van Vlijmen H; Karpusas M; Hsu YM; Zheng Z; Naismith JH; Thomas D
Protein Sci; 1998 May; 7(5):1124-35. PubMed ID: 9605317
[TBL] [Abstract][Full Text] [Related]
8. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
[TBL] [Abstract][Full Text] [Related]
9. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain.
Huang B; Eberstadt M; Olejniczak ET; Meadows RP; Fesik SW
Nature; 1996 Dec 19-26; 384(6610):638-41. PubMed ID: 8967952
[TBL] [Abstract][Full Text] [Related]
10. Another cell death induction system: TNF-alpha acts as a ligand for Fas in vaginal cells.
Suzuki A; Tsutomi Y; Shimizu M; Matsuzawa A
Cell Death Differ; 1999 Jul; 6(7):638-43. PubMed ID: 10453074
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
12. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
Gil J; Esteban M
Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis and NMR studies of the death domain of the tumor necrosis factor receptor-1.
Telliez JB; Xu GY; Woronicz JD; Hsu S; Wu JL; Lin L; Sukits SF; Powers R; Lin LL
J Mol Biol; 2000 Jul; 300(5):1323-33. PubMed ID: 10903872
[TBL] [Abstract][Full Text] [Related]
14. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
[TBL] [Abstract][Full Text] [Related]
15. CD40 and its crucial role as a member of the TNFR family.
Vogel LA; Noelle RJ
Semin Immunol; 1998 Dec; 10(6):435-42. PubMed ID: 9826576
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acid residues important for ligand binding to Fas.
Starling GC; Bajorath J; Emswiler J; Ledbetter JA; Aruffo A; Kiener PA
J Exp Med; 1997 Apr; 185(8):1487-92. PubMed ID: 9126929
[TBL] [Abstract][Full Text] [Related]
17. Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis.
Martin JH; Potthoff A; Ledig S; Cornberg M; Jandl O; Manns MP; Kubicka S; Flemming P; Athmann C; Beil W; Wagner S
Helicobacter; 2004 Oct; 9(5):371-86. PubMed ID: 15361075
[TBL] [Abstract][Full Text] [Related]
18. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively.
Kajiwara K; Saito A; Ogata S; Tanihara M
Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
20. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
